- Instruments
- Reagents and Kits
- Software and Services
Infectious Disease Point of Care Diagnostics Market size is valued at USD 2,547.8 million in 2021 and expected to grow at a significant CAGR of 7.2% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Global Infectious Disease Point of Care Diagnostics market and that can be segmented by components, by technique, by disease, and end-user. By components, The global infectious disease point of care diagnostics market has been segmented into Instruments, Reagents and Kits, Software and Services. The instruments segment is likely to be the largest and fastest-growing segment in terms of type. Based on technique, the global infectious disease point of care diagnostics market is segmented into Lateral flow immunoassay, Agglutination test, Molecular Diagnostics, and others. Among these, the lateral flow immunoassay segment is expected to have the fastest-growing market during the forecast period 2022-2028. By disease, the global infectious disease point of care diagnostics market is segmented into HIV, Hospital Acquired Infections, HBV, Respiratory Tract Infections, HPV, HCV, Tuberculosis, COVID-19, Others. The respiratory tract infections segment accounts for the largest share in 2021. Hospital acquired infections is the second-largest share during the forecast period 2021-2028. Based on the end-user, the market has been segregated into Home Care, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Others. The Hospitals and clinics segment is expected to dominate other segments in the global infectious disease point of care diagnostics market. The home care segment is expected to witness the highest CAGR during the forecast period according to precision business insights.
Key Development:
In April 2021 Chembio Diagnostics, Inc. launched the rapid point-of-care COVID-19/flu A&B test. The test provides results in 15 min.Infectious Diseases Point Of Care Poc Diagnostic Market Summary
Study Period
2023-29
Base Year
2022
CAGR
7.2%
Largest Market
Asia-Pacific
Fastest Growing Market
North-America
Infectious Diseases Point-of-Care (POC) Diagnostic Market
The key driving forces for the point-of-care infectious disease diagnostics market is to increase in the prevalence of infectious diseases such as HBV, HCV, HAIs, RTI, and others coupled with launch of advanced diagnostic test kits by the market players across the globe. Moreover, outbreak of COVID-19 drastically increased the revenue in 2020 and 2021.
North-America Got Significant Share
Infectious diseases Point-of-Care (POC) Diagnostic Market
North America market is expected to witness highest market share during the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Infectious Diseases Point Of Care Poc Diagnostic Market Segmentation
By Component Type
By Technology
- Lateral Flow Immunoassay
- Agglutination Test
- Molecular Diagnostics
- others
By Disease type
- HIV
- Hospital Acquired Infections
- HBV
- Respiratory Tract Infections
- HPV
- HCV
- Tuberculosis
- COVID-19
- Others
By End User
- Home Care
- Hospitals and Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Others
Frequently Asked Questions
The Infectious Diseases Point-of-Care (POC) Diagnostic Market is projected to expand at a CAGR of 7.2% during the forecast period.
The major players in the global infectious disease point of care diagnostics market are Cepheid Inc. (Danaher Corporation) (U.S.), Abbott Laboratories, Inc. (U.S.), Hoffmann La Roche Limited (Switzerland), Beckman Coulter, Inc. (U.S.), Siemens AG (Germany), Johnson & Johnson Services, Inc. (U.S.), Instrumentation Laboratory (U.S.), Becton, Dickinson, and Company (U.S.), Alere Inc. (U.S.), Nova Biomedical (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Quidel Corporation (U.S.)
North-America is the fastest-growing region for Infectious Diseases Point-of-Care (POC) Diagnostic Market
| 1. Executive Summary |
| 2. Global Infectious Disease Point of Care Diagnostics Market Introduction |
| 2.1. Global Infectious Disease Point of Care Diagnostics Market – Taxonomy |
| 2.2. Global Infectious Disease Point of Care Diagnostics Market –Definitions |
| 2.2.1. By Components |
| 2.2.2. By Technology |
| 2.2.3. By Disease Type |
| 2.2.4. By End User |
| 2.2.5. By Region |
| 3. Global Infectious Disease Point of Care Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Infectious Disease Point of Care Diagnostics Market Dynamic Factors - Impact Analysis |
| 3.6. Global Infectious Disease Point of Care Diagnostics Market – Competition Landscape |
| 3.7. Epidemiology |
| 4. Global Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Infectious Disease Point of Care Diagnostics Market, By Components, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1. Instruments |
| 5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Reagents and Kits |
| 5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Software and Services |
| 5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Infectious Disease Point of Care Diagnostics Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1. Lateral Flow Immunoassay |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Agglutination Test |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Molecular Diagnostics |
| 6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Infectious Disease Point of Care Diagnostics Market, Disease Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1. HIV |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Hospital Acquired Infections |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. HBV |
| 7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Respiratory Tract Infections |
| 7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5. HPV |
| 7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6. HCV |
| 7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Tuberculosis |
| 7.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 7.8. COVID-19 |
| 7.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.8.3. Market Opportunity Analysis |
| 7.9. Others |
| 7.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.9.3. Market Opportunity Analysis |
| 8. Global Infectious Disease Point of Care Diagnostics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1. Home Care |
| 8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Hospitals and Clinics |
| 8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostic Laboratories |
| 8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Academic and Research Institutes |
| 8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Others |
| 8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Global Infectious Disease Point of Care Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, By Technology, Disease Type, By End User, and Region, 2022-2028 |
| 10. North America Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 10.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Instruments |
| 10.1.2. Reagents and Kits |
| 10.1.3. Software and Services |
| 10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Lateral Flow Immunoassay |
| 10.2.2. Agglutination Test |
| 10.2.3. Molecular Diagnostics |
| 10.2.4. others |
| 10.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. HIV |
| 10.3.2. Hospital Acquired Infections |
| 10.3.3. HBV |
| 10.3.4. Respiratory Tract Infections |
| 10.3.5. HPV |
| 10.3.6. HCV |
| 10.3.7. Tuberculosis |
| 10.3.8. COVID-19 |
| 10.3.9. Others |
| 10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Home Care |
| 10.4.2. Hospitals and Clinics |
| 10.4.3. Diagnostic Laboratories |
| 10.4.4. Academic and Research Institutes |
| 10.4.5. Others |
| 10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028 |
| 10.7. North America Infectious Disease Point of Care Diagnostics Market Dynamics – Trends |
| 11. Europe Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 11.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Instruments |
| 11.1.2. Reagents and Kits |
| 11.1.3. Software and Services |
| 11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Lateral Flow Immunoassay |
| 11.2.2. Agglutination Test |
| 11.2.3. Molecular Diagnostics |
| 11.2.4. others |
| 11.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. HIV |
| 11.3.2. Hospital Acquired Infections |
| 11.3.3. HBV |
| 11.3.4. Respiratory Tract Infections |
| 11.3.5. HPV |
| 11.3.6. HCV |
| 11.3.7. Tuberculosis |
| 11.3.8. COVID-19 |
| 11.3.9. Others |
| 11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Home Care |
| 11.4.2. Hospitals and Clinics |
| 11.4.3. Diagnostic Laboratories |
| 11.4.4. Academic and Research Institutes |
| 11.4.5. Others |
| 11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028 |
| 11.7. Europe Infectious Disease Point of Care Diagnostics Market Dynamics – Trends |
| 12. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 12.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Instruments |
| 12.1.2. Reagents and Kits |
| 12.1.3. Software and Services |
| 12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Lateral Flow Immunoassay |
| 12.2.2. Agglutination Test |
| 12.2.3. Molecular Diagnostics |
| 12.2.4. others |
| 12.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. HIV |
| 12.3.2. Hospital Acquired Infections |
| 12.3.3. HBV |
| 12.3.4. Respiratory Tract Infections |
| 12.3.5. HPV |
| 12.3.6. HCV |
| 12.3.7. Tuberculosis |
| 12.3.8. COVID-19 |
| 12.3.9. Others |
| 12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Home Care |
| 12.4.2. Hospitals and Clinics |
| 12.4.3. Diagnostic Laboratories |
| 12.4.4. Academic and Research Institutes |
| 12.4.5. Others |
| 12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028 |
| 12.7. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Dynamics – Trends |
| 13. Latin America Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 13.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Instruments |
| 13.1.2. Reagents and Kits |
| 13.1.3. Software and Services |
| 13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Lateral Flow Immunoassay |
| 13.2.2. Agglutination Test |
| 13.2.3. Molecular Diagnostics |
| 13.2.4. others |
| 13.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. HIV |
| 13.3.2. Hospital Acquired Infections |
| 13.3.3. HBV |
| 13.3.4. Respiratory Tract Infections |
| 13.3.5. HPV |
| 13.3.6. HCV |
| 13.3.7. Tuberculosis |
| 13.3.8. COVID-19 |
| 13.3.9. Others |
| 13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Home Care |
| 13.4.2. Hospitals and Clinics |
| 13.4.3. Diagnostic Laboratories |
| 13.4.4. Academic and Research Institutes |
| 13.4.5. Others |
| 13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028 |
| 13.7. Latin America Infectious Disease Point of Care Diagnostics Market Dynamics – Trends |
| 14. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 14.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Instruments |
| 14.1.2. Reagents and Kits |
| 14.1.3. Software and Services |
| 14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Lateral Flow Immunoassay |
| 14.2.2. Agglutination Test |
| 14.2.3. Molecular Diagnostics |
| 14.2.4. others |
| 14.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. HIV |
| 14.3.2. Hospital Acquired Infections |
| 14.3.3. HBV |
| 14.3.4. Respiratory Tract Infections |
| 14.3.5. HPV |
| 14.3.6. HCV |
| 14.3.7. Tuberculosis |
| 14.3.8. COVID-19 |
| 14.3.9. Others |
| 14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Home Care |
| 14.4.2. Hospitals and Clinics |
| 14.4.3. Diagnostic Laboratories |
| 14.4.4. Academic and Research Institutes |
| 14.4.5. Others |
| 14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Infectious Disease Point of Care Diagnostics Market - Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028 |
| 14.7. MEA Infectious Disease Point of Care Diagnostics Market Dynamics – Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Cepheid Inc. (Danaher Corporation) (U.S.) |
| 15.2.2. Abbott Laboratories, Inc. (U.S.) |
| 15.2.3. Hoffmann La Roche Limited (Switzerland) |
| 15.2.4. Beckman Coulter, Inc. (U.S.) |
| 15.2.5. Siemens AG (Germany) |
| 15.2.6. Johnson & Johnson Services, Inc. (U.S.) |
| 15.2.7. Instrumentation Laboratory (U.S.) |
| 15.2.8. Becton, Dickinson and Company (U.S.) |
| 15.2.9. Alere Inc. (U.S.) |
| 15.2.10. Nova Biomedical (U.S.) |
| 15.2.11. Thermo Fisher Scientific Inc. (U.S.) |
| 15.2.12. Quidel Corporation (U.S.) |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Cepheid Inc. (Danaher Corporation) (U.S.)
- Abbott Laboratories, Inc. (U.S.)
- Hoffmann La Roche Limited (Switzerland)
- Beckman Coulter, Inc. (U.S.)
- Siemens AG (Germany)
- Johnson & Johnson Services, Inc. (U.S.)
- Instrumentation Laboratory (U.S.)
- Becton, Dickinson and Company (U.S.)
- Alere Inc. (U.S.)
- Nova Biomedical (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Quidel Corporation (U.S.)